What have we learned from Lupus/APS registries?
GLADEL
Bernardo Pons-Estel
RELESSAR
Mercedes García
APS ACTION
Maria Laura Bertolaccini
GESAF SAR
Romina Nieto
Obstetric EURO APS
Jaume Alijotas-Reig
APS: A journey from undefined to defined
Cellular and molecular immunologic mechanisms of antiphospholipid antibodies in APS
Jason Knight
Antiphospholipid antibodies as tools for antiphospholipid syndrome patient stratification
Ali Duarte-Garcia
Disease activity, damage, risk scores, and classification criteria in APS
Damage index in APS
Maria Victoria Goycochea
Quality of life in APS
Mary-Carmen Amigo
Joint session: ISTH SSC aPL/LA
Additional testing in antiphospholipid syndrome: role of non¬criteria antiphospholipid antibodies
Vittorio Pengo
The value of aPL positivity by system
The ears
Diego Sifuentes
Cardiac manifestations in APS
Dr Alvaro Danza
The cells and APS
Monocytes
Chary Lopez-Pedrera
Endothelial cells
Pier Luigi Meroni
The thrombotic storm APS
What mimics APS?
Gerard Espinosa
The thrombotic storm in pregnancy
Jaume Alijotas-Reig
Catastrophic APS
Ricard Cervera
What clinicians should know on laboratory testing for aPL?
How to test/interpret aPL results in patients during anticoagulant therapy?
Ricardo Forastiero
Fluctuations of aPL over time
Angela Tincani
Preeclampsia and APS: Present and future
Preeclampsia and APS: What is the current evidence?
Ware Branch
New specificities in aPL
Domain 4/5 of B2GPI
Pier Luigi Meroni
Prevention & Treatment of obstetric APS
Prevention and management of placental dysfunction in APS
Guillherme de Jesus
Should we use biologics in pregnancy?
Ware Branch
Noncriteria obstetric APS
Laura Andreoli
Mechanisms of aPL mediated pregnancy morbidity
Do obstetric and thrombotic aPL have differential mechanisms and effects in target cells
Pier Luigi Meroni
Targets to prevent obstetric APS
Jaume Alijotas-Reig
COVID19 and APS
Vaccine induced thrombotic thrombocytopenia (VITT)
Cecillia Colorio
COVID19 vaccines and aPL/APS
Vittorio Pengo
Does aPL impact the management strategy in lupus?
The impact of aPL in lupus
Guillermo Ruiz-Irastorza
Is it lupus? Lupus Nephritis vs. MAPS
Maria Jose Cuadrado
Cardiovascular risk in lupus
Anisur Rahman
Neuropsychiatric APS
Neuropsychiatric APS
Giovanni Sanna
Prevention & Treatment of thrombotic & Nonthrombotic APS
Influence of cardiovascular risk control in thrombotic APS: evidence or common sense?
Silvia Foddai
Nonthrombotic manifestations of APS
Danieli Andrade
Pediatric APS
Babies born to APS mothers
Angela Tincani
Management of APS in children
Teruya Jun
What have we learned from pediatric cohorts?
Barry Myones
The years in review: 2019/2022
Chairs:
Paula Alba
Guillermo Pons-Estel
Maria Laura Bertolaccini
Bernardo Pons-Estel
Basic: Jason Knight
Clinic: Danieli Andrade
